These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9293746)

  • 41. [The evaluation of methods for determinations of urinary oxalate].
    Egoshi K; Akakura K; Ueda T; Takei K; Ito H
    Nihon Hinyokika Gakkai Zasshi; 1999 Jul; 90(7):675-80. PubMed ID: 10481474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new era in the treatment of calcium oxalate stones?
    Ivanovski O; Drüeke TB
    Kidney Int; 2013 Jun; 83(6):998-1000. PubMed ID: 23728004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Results of dietary evaluation during calcium oxalate and calcium phosphate lithiasis].
    Mahe JL; Cledes J; Bigot JC; Bardou LG; Morel MA
    Nephrologie; 1993; 14(6):291-7. PubMed ID: 8145888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis risk in rats.
    Grases F; Ramis M; Costa-Bauzá A; March JG
    J Ethnopharmacol; 1995 Mar; 45(3):211-4. PubMed ID: 7623486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
    Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of magnesium and pH on experimental calcium oxalate stone disease.
    Borden TA; Lyon ES
    Invest Urol; 1969 Jan; 6(4):412-22. PubMed ID: 5773525
    [No Abstract]   [Full Text] [Related]  

  • 48. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.
    Jiang Z; Asplin JR; Evan AP; Rajendran VM; Velazquez H; Nottoli TP; Binder HJ; Aronson PS
    Nat Genet; 2006 Apr; 38(4):474-8. PubMed ID: 16532010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of the oxalate precursors on experimental calcium oxalate urolithogenesis in rats: acute and chronic administration].
    Morozumi M; Ogawa Y
    Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):1022-7. PubMed ID: 7596078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diet in urolithiasis].
    Bach D; Vahlensieck W
    Schwest Rev; 1977 Nov; 15(11):8-12. PubMed ID: 245019
    [No Abstract]   [Full Text] [Related]  

  • 51. A contribution to the formation mechanism of calcium oxalate urinary calculi. II. In vitro experiments concerning the theory of the formation of Whewellite and Weddellite urinary calculi.
    Hesse A; Berg W; Schneider HJ; Hienzsch E
    Urol Res; 1976; 4(4):157-60. PubMed ID: 14431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of dietary intake on urinary oxalate excretion in calcium renal stone formers.
    Masai M; Ito H; Kotake T
    Br J Urol; 1995 Dec; 76(6):692-6. PubMed ID: 8535710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chemical and crystallographic aspects of calcium oxalate calculosis].
    BORGNO M; MARTEN PEROLINO R
    Minerva Urol; 1962; 14():1-17. PubMed ID: 13871324
    [No Abstract]   [Full Text] [Related]  

  • 54. Urinary enzymes and calcium oxalate urolithiasis.
    Khan SR; Shevock PN; Hackett RL
    J Urol; 1989 Sep; 142(3):846-9. PubMed ID: 2570167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re: The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Assimos DG
    J Urol; 2013 Oct; 190(4):1268. PubMed ID: 24029325
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization of histone (H1B) oxalate binding protein in experimental urolithiasis and bioinformatics approach to study its oxalate interaction.
    Latha P; Kalaiselvi P; Varalakshmi P; Rameshkumar G
    Biochem Biophys Res Commun; 2006 Jun; 345(1):345-54. PubMed ID: 16690032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of long-term pyridoxine administration on serum and urinary values of calculi-forming substances in Ca-oxalate urolithiasis].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Vnitr Lek; 1978 May; 24(5):445-50. PubMed ID: 96593
    [No Abstract]   [Full Text] [Related]  

  • 58. Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
    Lewandowski S; Rodgers AL
    Clin Chim Acta; 2004 Jul; 345(1-2):17-34. PubMed ID: 15193974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Urinary oxalate in renal lithiasis].
    Desgrez P; Thomas J; David-Issartel L
    Rein Foie; 1968; 11():211-20. PubMed ID: 5741321
    [No Abstract]   [Full Text] [Related]  

  • 60. Idiopathic calcium oxalate urolithiasis and endogenous oxalate production.
    Baker PW; Rofe AM; Bais R
    Crit Rev Clin Lab Sci; 1996; 33(1):39-82. PubMed ID: 8833627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.